A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. (Q39371837)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. |
scientific article |
Statements
1 reference
A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. (English)
1 reference
Lin Chang
1 reference
Vanessa Z Ameen
1 reference
George E Dukes
1 reference
David J McSorley
1 reference
Eric G Carter
1 reference
Emeran A Mayer
1 reference
1 January 2005
1 reference
1 reference
100
1 reference
1
1 reference
115-123
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference